An interview with Amy Dow, attorney with Epstein Becker Green.
It is well known that medical device companies rely heavily upon input from physicians to help identify and develop new ideas for innovative medical devices. But how will the impending Sunshine Act affect the relationships between manufacturers and physicians? Are there any loopholes? As a medical device professional, what else should you know about the Sunshine Act?
|Amy Dow, Epstein Becker Green|
In this interview, Amy Dow, attorney with Epstein Becker Green, helps us understand the requirements of the Sunshine Act and the issues surrounding its implementation. Amy currently represents medical device, pharmaceutical, and biotech companies on a wide variety of compliance and regulatory matters and is considered a leading expert on the Sunshine Act. Read on for her thought-provoking insight regarding the potential ramifications of the Sunshine Act.
What You Will Learn:
Listen to the "The Essential Elements of the Sunshine Act and the Corresponding Impact on Medical Device Companies" podcast (right click and select "Save Link As" to download the podcast).
Download the PDF action points of the "The Essential Elements of the Sunshine Act and the Corresponding Impact on Medical Device Companies" podcast.